Teladoc Health, Inc. (TDOC) DCF Valuation
Why we don't show a single “fair value” for TDOC
Even the conservative scenario ($16.78) sits far above today's price — trailing cash flows may be cyclically elevated. The honest lens is the question below: what growth does today's price actually require? The model scenarios are listed further down for reference.
What would today's price require?
$7.58 is justified only if free cash flow grows about -10.7% a year (fading to 2.5% long-run) at a 11.5% required return — slower than the company has actually grown.
| Scenario | FCF growth (fading to 2.5%) | Discount | Value / share |
|---|---|---|---|
| Conservative | 10.0%/yr | 12.5% | $16.78 |
| Base case | 13.0%/yr | 11.5% | $21.37 |
| Optimistic | 16.0%/yr | 10.5% | $27.56 |
| Analyst DCF (FMP) | independent reference — different model | $17.14 | |
Current Price
$7.58
Market-Implied Growth
-10.7%/yr
vs +13.0% 5Y actual
Base-Case Model Value
$21.37
model output — not a price target
TDOC DCF Fair Value Calculator
Edit the assumptions to see how they change the estimated fair value. Opens seeded with TGM's data-driven base case for TDOC (growth from its own 5-year record, discount from its beta), so the sandbox starts where the scenarios above leave off. Illustrative model — not investment advice.
Base inputs: FCF $238.3M · 0.18B shares · net debt $224.9M
Estimated Fair Value
$30.15
+297.8% vs $7.58
Sensitivity — fair value by discount rate × terminal growth
How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 13.0%/yr FCF growth and 10-year horizon fixed. Green = above today's $7.58; red = below. Your current case is outlined.
| WACC ↓ / Terminal → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 9.5% | $37.45 | $39.10 | $40.99 | $43.16 | $45.70 |
| 10.5% | $32.33 | $33.53 | $34.87 | $36.39 | $38.12 |
| 11.5% | $28.29 | $29.17 | $30.15 | $31.25 | $32.49 |
| 12.5% | $25.01 | $25.69 | $26.43 | $27.24 | $28.15 |
| 13.5% | $22.32 | $22.84 | $23.41 | $24.03 | $24.71 |
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita